The list of publications in 2013
1. Novik A.A., T.A. Ionova. The study of the quality of life in pediatrics (2nd edition, revised and enlarged) / ed. by Y.L. Shevchenko. Moscow: Publishing house RANS, 2013. 136 p. (In Russian)
2. Zakharova R.N. Validation of the Russian version of the RAND SF-36 questionnaire in Yakutia / R.N. Zakharova, Mikhailova A.E., Ionova T.I., Krivoshapkin V.G. // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 27-30. (In Russian)
3. Ionova T.I. Quality of life and problems posed by hypoglycemia in type 2 diabetes mellitus during oral hypoglycemic therapy / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Clinical Medicine. – 2013. – Vol. 9: 34-44. (In Russian)
4. Ionova T.I. Quality of life and problems posed by hypoglycemia in type 2 diabetes mellitus during oral hypoglycemic therapy / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 34-40. (In Russian)
5. Ionova T.I. Quality of life and hypoglycemia in type 2 diabetes patients on basal-bolus insulin therapy / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 72-83. (In Russian)
6. Ionova T.I. Hypoglycemia problems in patients with type 2 diabetes receiving traditional and innovative oral hypoglycemic therapy / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 64–71. (In Russian)
7. Ionova T.I. Quality of life and symptom profile in patients with chronic myeloid leukemia receiving dasatinib as à second-line therapy due to intolerance or resistance to imatinib / T.I. Ionova,, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // Clinical Oncohematology. – 2013. – Vol. 6 (2): 166–176. (In Russian)
8. Ionova T.I. Patient-reported outcomes in patients with chronic myeloid leukemia in chronic phase during second-line treatment with dasatinib / T.I. Ionova,, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 32–41. (In Russian)
9. Ionova T.I. Patient-reported outcomes in patients with chronic myeloid leukemia in chronic phase during second-line treatment with dasatinib / T.I. Ionova,, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 53–56. v
10. Ionova T.I. Quality of life and symptom profile in patients with imatinib-resistant or imatinib-intolerant chronic myeloid leukemia / / T.I. Ionova, D.A. Fedorenko, T.P. Nikitina, K.A. Kurbatova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 20–31. (In Russian)
11. Klassen R. The value of patient-reported outcomes in pediatric onco-hematology / R. Klassen, T. Ionova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 121–125. (In Russian)
12. Moiseenko Eu.I. Quality of life in childhood cancer survivors and in their parents / Eu.I. Moiseenko, T.P. Nikitina, K.A. Kurbatova, T.I. Ionova // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 92–95. (In Russian)
13. Moiseenko Eu.I. Quality of life in childhood cancer survivors and in their parents / Eu.I. Moiseenko, T.P. Nikitina, K.A. Kurbatova, T.I. Ionova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 91–103. (In Russian)
14. Nikitina T.P. Validation of the Russian version of the questionnaire for assessing patient's experience of hypoglycemia - Hypoglycemia perspectives questionnaire (with event frequency items) / T.P. Nikitina, K.A. Kurbatova, T.I. Ionova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 109–120. (In Russian)
15. Nikitina T.P. Quality of life and hypoglycemia burden in patients with type 2 diabetes mellitus on basal-bolus insulin therapy / T.P. Nikitina, V.I. Odin, K.A. Kurbatova, N.E. Shablovskaya, T.I. Ionova // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 127–130. (In Russian)
16. Salek S. Value of Patient-Reported Outcomes / T.I. Ionova, S. Salek // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 5–7.
17. Usacheva E.I. Value of Patient-Reported Outcomes in the practice of the hematologist: clinical observation / E.I. Usacheva, T.P. Nikitina // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 138–141. (In Russian)
18. Fedorenko D.A. Prognostic value of quality of life data in patients with malignant lymphomas undergoing autologous hematopoietic stem cell transplantation / D.A. Fedorenko, T.I. Ionova // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 47–55. (In Russian)
19. Shevchenko Y.L. High dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in patients with progressive and relapsing-remitting types of multiple sclerosis: clinical response and quality of life / Y.L. Shevchenko, A.N. Kuznetsov, Y.N. Fedotov., V.Y. Melnichenko, T.I. Ionova, D.A. Fedorenko, A.V. Kartashov, R.V. Kruglina, K.A. Kurbatova, A.A. Novik // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (3, supplement): 14-17. (In Russian)
20. Shevchenko Y.L. Comprehensive approach for treatment efficacy assessment in multiple sclerosis patients undergoing high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation / Y.L. Shevchenko, A.N. Kuznetsov, Y.N. Fedotov, V.Y. Melnichenko, T.I. Ionova, D.A. Fedorenko, A.V. Kartashov, R.V. Kruglina, K.A. Kurbatova, A.A. Novik // Bulletin of the Multinational Center of Quality of Life Research. – 2013. – Vol. 21-22: 7-19. (In Russian)
21. Fedorenko D.A. Autologous haematopoietic stem cell transplantation in lymphomas: clinical outcomes / D.A. Fedorenko, V.Y. Melnichenko, T.I. Ionova, N.E. Mochkin, K.A. Kurbatova // Bulletin of Pirogov National Medical and surgical center. – 2013. – Vol. 8 (4): 62-65. (In Russian)
22. Ionova T.I. Modern issues of life quality research in haematology // Siberian scientific medical journal. – 2013. – Vol. 33 (1): 82-89. (In Russian)
23. Kirsch M. Understanding the importance of using patient-reported outcome measures in patients with immune thrombocytopenia / M. Kirsch, R. Klaassen, S. De Geest, A. Matzdorff, T. Ionova, F. Dobbels // Seminars in Hematology. - 2013. - Vol. 50 (1): 39–42.
24. Salek S. Patients' needs in hematology: whose perspectives? / S. Salek, T. Ionova, E. Oliva // Haematologica. – 2013. – Vol. 98: 828–830; doi: 10.3324.
25. Ionova T. Benefits/risks of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: physician's and patient's perspective / T. Ionova, T. Nikitina, T. Gritsenko, V. Ivanova, G. Kuchma, T. Shnaider, I. Sannikova, D. Fedorenko, K. Kurbatova // Haematologica. 2013 (Suppl.). B1381.
26. Ionova T.I. Efficacy of dasatinib therapy in patients with imatinib-resistant or -intolerant chronic myeloid leukemia from physician's and patient's perspective: «real world» data / T.I. Ionova, T.P. Nikitina, T.A. Gritsenko, V.L. Ivanova, G.B. Kuchma, T.V. Shnaider, I.V. Sannikova, D.A. Fedorenko, K.A. Kurbatova // Blood. 2013; 122: 5185.
27. Ionova T.I. Usefulness of the hypoglycemia perspectives questionnaire (HPQ) in management of patients with type 2 diabetes / T.I. Ionova, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Value in Health. 2013. Vol. 16 (7): PDB90.
28. Ionova T.I. How hypoglycemia impacts quality of life and treatment satisfaction in type 2 diabetes mellitus patients on basal-bolus insulin therapy? / T.I. Ionova, V.I. Odin, K.A. Kurbatova, N.E. Shablovskaya // Value in Health. 2013. Vol. 16 (7): PDB88.
29. Ionova T.I. Benefits of vildagliptin plus metformin combination therapy in type 2 diabetes mellitus (T2DM) from patient's perspective: quality of life (QOL) and hypoglycemia burden analysis / T.I. Ionova, V.I. Odin, T.P. Nikitina, K.A. Kurbatova, N.E. Shablovskaya // Value in Health. 2013. Vol. 16 (7): PDB91.
30. Ionova T. Is symptom assessment of value in lymphoma survivors after autologous haematopoietic stem cell transplantation (AHSCT)? / T. Ionova, D. Fedorenko, N. Mochkin, K. Kurbatova, G. Gorodokin, A. Novik // Haematologica. 2013 (Suppl.). B1674.
31. Fedorenko D.A. Quality of life in lymphoma survivors after autologous hematopoietic stem cell transplantation (AHSCT) / D.A. Fedorenko, N.E. Mochkin, K.A. Kurbatova, V.Y. Melnichenko, T.I. Ionova // Bone Marrow Transplantation Journal. 2013. Vol. 48 (S2): P1161, S422.
| 
